420 With CNW - Marijuana Rescheduling Likely To Reduce Barriers To Research

5/16/2024 11:13:50 PM

(MENAFN- Investor Brand Network) The Biden administration's move to
reclassify cannabis as a less hazardous substance
is anticipated to ease some of the limitations on research. However, experts caution that while the change will alleviate certain restrictions, it won't eliminate all of them. Additionally, it may not necessarily reduce the potential risks associated with cannabis or enhance users' understanding of those risks.

Currently, cannabis is categorized as a Schedule I substance , indicating it is deemed to have a high abuse potential and no recognized medical value. The proposed shift by...

NOTE TO INVESTORS:
The latest news and updates relating to Astrotech Corp. (NASDAQ: ASTC) are available in the company's newsroom at

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text
CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:
/Disclaimer

CannabisNewsWire
Denver, CO

303.498.7722 Office
...

CannabisNewsWire is powered by
IBN

MENAFN16052024000224011066ID1108224630

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.